Trial Profile
PROSPECTIVE STUDY OF MELPHALAN, PREDNISOLONE AND LENALIDOMIDE IN THE TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Melphalan (Primary) ; Prednisolone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 24 Jul 2013 Planned End Date changed to 23 Dec 2013.
- 24 Jul 2013 New trial record